{"nctId":"NCT01944098","briefTitle":"Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients","startDateStruct":{"date":"2013-08"},"conditions":["Bariatric Surgical Pain"],"count":20,"armGroups":[{"label":"Lidocaine","type":"EXPERIMENTAL","interventionNames":["Drug: Lidocaine"]},{"label":"Placebo","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Lidocaine","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adult patients between the ages of 18-65 years old\n* BMI ≥ 40 kg/m2, ≤ 60 kg/m2\n* Undergoing a primary laparoscopic RYGB by Dr. Murr\n* Agree to be followed 24 hours postoperatively\n* Normal K+ and Mg++ serum levels\n\nExclusion Criteria:\n\n* BMI less than 40 kg/m2, \\> 60 kg/m2\n* Laparoscopic RYGB surgery performed by a surgeon other than Dr. Murr\n* Allergy to lidocaine\n* Allergy to hydromorphone or ketorolac\n* Allergy to corn or amide anesthetics\n* Use of (thioridizine)\n* Pregnancy\n* Abnormalities of ALT or AST\n* Intra-operative diagnosis of cirrhosis or portal hypertension\n* Intraoperative complications per surgeon\n* Intraoperative extensive adhesions per surgeon\n* Chronic pain syndrome and chronic use of narcotics\n* Severe back pain secondary to degenerative joint disease","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Postoperative Pain","description":"Analysis of patient outcome will involve a series of visual analogue scale pain evaluations during mobilization, coughing, and resting. VAS, 0 cm as no pain - 10 cm as maximum pain","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"4.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]}]},{"type":"PRIMARY","title":"Postoperative Pain","description":"Analysis of patient outcome will involve a series of visual analogue scale (VAS, 0 cm as no pain - 10 cm as maximum pain) pain evaluations during mobilization, coughing, and resting","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]},{"type":"PRIMARY","title":"Postoperative Pain","description":"Analysis of patient outcome will involve a series of visual analogue scale (VAS, 0 cm as no pain - 10 cm as maximum pain) pain evaluations during mobilization, coughing, and resting","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":null},{"groupId":"OG001","value":"4.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"6.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]},{"type":"PRIMARY","title":"Postoperative Pain","description":"Analysis of patient outcome will involve a series of visual analogue scale pain evaluations during mobilization, coughing, and resting. VAS, 0 cm as no pain - 10 cm as maximum pain","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"5.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"4.5","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":["Dizziness","Metallic Taste in Mouth","Significant Blood Pressure Changes"]}}}